A. Wiland

987 total citations
20 papers, 698 citations indexed

About

A. Wiland is a scholar working on Transplantation, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, A. Wiland has authored 20 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Transplantation, 5 papers in Surgery and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in A. Wiland's work include Renal Transplantation Outcomes and Treatments (15 papers), Neurological Complications and Syndromes (4 papers) and Organ Transplantation Techniques and Outcomes (4 papers). A. Wiland is often cited by papers focused on Renal Transplantation Outcomes and Treatments (15 papers), Neurological Complications and Syndromes (4 papers) and Organ Transplantation Techniques and Outcomes (4 papers). A. Wiland collaborates with scholars based in United States and France. A. Wiland's co-authors include David K. Klassen, Charles B. Cangro, Stephen T. Bartlett, John C. Papadimitriou, Matthew R. Weir, Jeffrey C. Fink, Cinthia B. Drachenberg, Steven A. Blahut, Cinthia B. Drachenberg and Dharmesh Patel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and The Journal of Urology.

In The Last Decade

A. Wiland

20 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Wiland United States 10 371 347 167 113 109 20 698
J. Miller United States 18 513 1.4× 731 2.1× 139 0.8× 60 0.5× 185 1.7× 101 1.1k
C F Barker United States 9 406 1.1× 342 1.0× 122 0.7× 44 0.4× 67 0.6× 19 729
Angello Lin United States 12 270 0.7× 318 0.9× 119 0.7× 71 0.6× 58 0.5× 32 849
Christine Chamberlain United States 10 223 0.6× 200 0.6× 95 0.6× 183 1.6× 44 0.4× 16 749
John J. Rynasiewicz United States 10 196 0.5× 286 0.8× 106 0.6× 58 0.5× 95 0.9× 12 519
Harold C. Yang United States 16 559 1.5× 379 1.1× 111 0.7× 69 0.6× 37 0.3× 33 912
Manuel Arias Spain 13 422 1.1× 195 0.6× 82 0.5× 71 0.6× 20 0.2× 21 664
Eileen W. Tsai United States 14 324 0.9× 143 0.4× 51 0.3× 144 1.3× 126 1.2× 16 647
Sollinger Hw United States 18 378 1.0× 670 1.9× 88 0.5× 47 0.4× 59 0.5× 71 891
B. W. Shaw United States 10 256 0.7× 569 1.6× 121 0.7× 31 0.3× 48 0.4× 14 776

Countries citing papers authored by A. Wiland

Since Specialization
Citations

This map shows the geographic impact of A. Wiland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Wiland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Wiland more than expected).

Fields of papers citing papers by A. Wiland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Wiland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Wiland. The network helps show where A. Wiland may publish in the future.

Co-authorship network of co-authors of A. Wiland

This figure shows the co-authorship network connecting the top 25 collaborators of A. Wiland. A scholar is included among the top collaborators of A. Wiland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Wiland. A. Wiland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bloom, Roy D., Jennifer Trofe‐Clark, A. Wiland, & Rita R. Alloway. (2013). A randomized, crossover pharmacokinetic study comparing generic tacrolimus vs. the reference formulation in subpopulations of kidney transplant patients. Clinical Transplantation. 27(6). E685–93. 12 indexed citations
3.
Alloway, Rita R., Basma Sadaka, Jennifer Trofe‐Clark, A. Wiland, & Roy D. Bloom. (2012). A Randomized Pharmacokinetic Study of Generic Tacrolimus Versus Reference Tacrolimus in Kidney Transplant Recipients. American Journal of Transplantation. 12(10). 2825–2831. 54 indexed citations
4.
Brennan, Daniel C., Christophe Legendre, Dharmesh Patel, et al.. (2011). Cytomegalovirus Incidence Between Everolimus Versus Mycophenolate in De Novo Renal Transplants: Pooled Analysis of Three Clinical Trials. American Journal of Transplantation. 11(11). 2453–2462. 120 indexed citations
5.
6.
Papadimitriou, John C., Charles B. Cangro, Amr S. Khaled, et al.. (2003). Histologic Features of Mycophenolate Mofetil-Related Colitis: A Graft-Versus-Host Disease-Like Pattern. International Journal of Surgical Pathology. 11(4). 295–302. 118 indexed citations
7.
Wiland, A., Jeffrey C. Fink, Benjamin Philosophe, et al.. (2001). Peripheral administration of thymoglobulin for induction therapy in pancreas transplantation. Transplantation Proceedings. 33(1-2). 1910–1910. 16 indexed citations
8.
Papadimitriou, J. C., Cinthia B. Drachenberg, Charles B. Cangro, et al.. (2001). Graft-versus-host disease-like features in mycophenolate mofetil-related colitis. Transplantation Proceedings. 33(3). 2237–2238. 34 indexed citations
9.
Philosophe, Benjamin, Alan C. Farney, Eugene J. Schweitzer, et al.. (2000). Simultaneous pancreas-kidney (SPK) and pancreas living-donor kidney (SPLK) transplantation at the University of Maryland.. PubMed. 211–6. 5 indexed citations
10.
Drachenberg, Cinthia B., David K. Klassen, Matthew R. Weir, et al.. (1999). ISLET CELL DAMAGE ASSOCIATED WITH TACROLIMUS AND CYCLOSPORINE: MORPHOLOGICAL FEATURES IN PANCREAS ALLOGRAFT BIOPSIES AND CLINICAL CORRELATION1. Transplantation. 68(3). 396–402. 244 indexed citations
11.
Wiland, A., et al.. (1999). PERIPHERAL AND OUTPATIENT ADMINISTRATION OF ANTITHYMOCYTE GLOBULIN (ATGAM®). Transplantation. 67(7). S185–S185. 1 indexed citations
12.
Keay, S., S Blahut, L.H. Anderson, et al.. (1999). Increased Incidence of Post-Transplant Lymphoproliferative Disorder Associated with Mycophenolate Mofetil in Kidney Transplant Recipients. Transplantation. 67(7). S218–S218. 1 indexed citations
13.
Papadimitriou, John C., Cinthia B. Drachenberg, A. Wiland, et al.. (1999). HISTOLOGICAL MORPHOLOGY OF COLITIS ASSOCIATED WITH MYCOPHENOLATE MOFETIL (MMF) IN RENAL ALLOGRAFT RECIPIENTS: ACUTE GRAFT VERSUS HOST DISEASE (GVH)-LIKE FEATURES.. Transplantation. 67(7). S256–S256. 3 indexed citations
14.
Nogueira, Joseph M., Charles B. Cangro, Jeffrey C. Fink, et al.. (1999). A Comparison of Recipient Renal Outcomes With Laparoscopic Versus Open Live Donor Nephrectomy. The Journal of Urology. 162(3 Part 1). 963–964. 6 indexed citations
15.
Bartlett, Stephen T., Alan C. Farney, Bruce E. Jarrell, et al.. (1998). Kidney transplantation at the University of Maryland.. PubMed. 177–85. 12 indexed citations
16.
Schweitzer, Eugene J., Jeffrey C. Fink, A. Wiland, et al.. (1998). MYCOPHENOLATE MOFETIL REDUCES THE RISK OF ACUTE REJECTION LESS IN AFRICAN-AMERICAN THAN IN CAUCASIAN KIDNEY RECIPIENTS1. Transplantation. 65(2). 242–248. 37 indexed citations
17.
Schweitzer, Eugene J., A. Wiland, Alan C. Farney, et al.. (1998). THE SHRINKING RENAL REPLACEMENT THERAPY "BREAK-EVEN" POINT. Transplantation. 66(8). S5–S5. 1 indexed citations
18.
Papadimitriou, John C., A. Wiland, Cinthia B. Drachenberg, David K. Klassen, & S. T. Bartlett. (1998). Effectiveness of immunosuppressive treatment for recurrent or refractory pancreas allograft rejection: correlation with histologic grade. Transplantation Proceedings. 30(8). 3945–3945. 2 indexed citations
19.
Keay, Susan, David Oldach, A. Wiland, et al.. (1998). Posttransplantation Lymphoproliferative Disorder Associated with OKT3 and Decreased Antiviral Prophylaxis in Pancreas Transplant Recipients. Clinical Infectious Diseases. 26(3). 596–600. 26 indexed citations
20.
Papadimitriou, John C., Cinthia B. Drachenberg, A. Wiland, et al.. (1998). RESPONSE TO IMMUNOSUPPRESSIVE TREATMENT FOR PANCREAS ALLOGRAFT REJECTION ACCORDING TO HISTOLOGIC GRADE. Transplantation. 65(Supplement). 251–251. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Miller Breakdown of academic impact, for papers by C F Barker Breakdown of academic impact, for papers by Angello Lin Breakdown of academic impact, for papers by Christine Chamberlain Breakdown of academic impact, for papers by John J. Rynasiewicz Breakdown of academic impact, for papers by Harold C. Yang Breakdown of academic impact, for papers by Manuel Arias Breakdown of academic impact, for papers by Eileen W. Tsai Breakdown of academic impact, for papers by Sollinger Hw Breakdown of academic impact, for papers by B. W. Shaw
Rankless by CCL
2026